Khosla Ventures
Listed as “Kamau Therapeutics”
- First observed:
- 31 Oct 2026
- Investment announced:
- Date not recorded
Kamau Therapeutics
Company website description: Kamau Therapeutics is a clinical-stage gene correction company focused on developing curative, single-dose precision therapies for serious genetic diseases using high-efficiency targeted DNA integration.
- Tracked VC backers
- 1
Publicly documented VC backing
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
Dated public activity
No dated funding or investment events are recorded yet. Initial portfolio listings establish the starting baseline and earn no points.